Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
5.44M
-
Shares change
-
+2.4M
-
Total reported value, excl. options
-
$2.27M
-
Value change
-
+$1M
-
Number of buys
-
17
-
Number of sells
-
-5
-
Price
-
$0.42
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q3 2025
37 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q3 2025.
IGC Pharma, Inc. - COM NEW (IGC) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.44M shares
.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (1.22M shares), VANGUARD GROUP INC (1.15M shares), GEODE CAPITAL MANAGEMENT, LLC (852K shares), BlackRock, Inc. (704K shares), CITADEL ADVISORS LLC (628K shares), STATE STREET CORP (160K shares), NORTHERN TRUST CORP (113K shares), Virtu Financial LLC (89.5K shares), DEARBORN PARTNERS LLC (84.4K shares), and GOLDMAN SACHS GROUP INC (65.5K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.